Overview

Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy.

Status:
Terminated
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to compare the long term effectiveness, safety and tolerability of carisbamate compared to two other frequently prescribed anti-epileptic drugs (AEDs) in patients with epilepsy.
Phase:
Phase 3
Details
Lead Sponsor:
SK Life Science
SK Life Science, Inc.
Treatments:
Anticonvulsants
Etiracetam
Levetiracetam
Piracetam
Topiramate